DAPSA versus cDAPSA: do we need to use CRP?
RSG Gonçalves, LM de Almeida Martins… - Annals of the …, 2020 - ard.bmj.com
Discussion The main problem in clinical routine is which one measure of disease is more
appropriated. Not all measures of disease activity in PsA included an inflammatory marker in …
appropriated. Not all measures of disease activity in PsA included an inflammatory marker in …
[HTML][HTML] Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever
A Ranzolin, CDL Marques, LF da Rocha Junior… - Advances in …, 2022 - Springer
Abstract Background/Objective The effects of Chikungunya virus (CHIKV) infection on
patients with rheumatic diseases have not been extensively studied. Our aim was to …
patients with rheumatic diseases have not been extensively studied. Our aim was to …